From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
“ICyte Benchmarks enable us to understand key pricing and contracting market trends so we can quickly and accurately adjust and optimize our market access strategy.”
Vice President | Market Access
ICyte technology offers benchmark data for brand and gross-to-net by therapeutic type, class, distribution channels, and a class-of-trade.
Market access strategies are not static; they need to adjust and evolve as the market segment, patient population behavior, and competition changes. Unfortunately, pharmaceutical market access teams are often faced with a ton of questions, but little trustworthy market data.
ICyte Benchmarks provides data-driven insights that help address common market access questions and challenges including:
Channel Design analogs provide a clear view of the distribution, channel mix and pathway to the provider/patient for a competitive or analog market baskets
Gross-to-Net waterfall and line-item models based on competitive or analog market basket
Point-of-Care analogs provide dispenser and site care deciles at an address and class of trade level based on a competitive or analog market basket
With Contract Benchmarks, pharma manufacturers can leverage our repository of terms, clauses, and timing and performance criteria
Trade & market access leaders will align on optimal channel design, using syndicated data to capture how the product is distributed to points of care or to identify missing points-of-care.
Channel Design Analogs provide a clear view of the distribution, channel mix, and pathway to the provider/patient for a competitive or analog market basket(s):
Finance leaders can build a consensus GTN forecast with accurate data history and reliable, comparable industry benchmarks
GTN Analogs offer GTN waterfall and line item models based on competitive or analog market basket(s):
Commercial teams are able to prioritize site/point-of-care programs without worrying about gaps in available market data.
POC analogs provide dispenser and site of care deciles at an address and class of trade level based on a competitive or analog market basket(s):
Contract executives stay up-to-date with new or common best practices outside their company or product portfolio, allowing them to make optimal data-driven decisions about contract strategy and contract negotiations.
IntegriChain can leverage its repository of terms, clauses, timing, and performance criteria to develop better contracts with:
Explore our Consulting Services
Using ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
Read the Blog
Learn more about IntegriChain’s comprehensive Commercial Roadmap to Launch Program for both emerging and established companies preparing for product launch
Learn More
